Genome Editing Provides New Insights into Receptor-Controlled Signalling Pathways

Graeme Milligan, Asuka Inoue

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Rapid developments in genome editing, based largely on CRISPR/Cas9 technologies, are offering unprecedented opportunities to eliminate the expression of single or multiple gene products in intact organisms and in model cell systems. Elimination of individual G protein-coupled receptors (GPCRs), both single and multiple G protein subunits, and arrestin adaptor proteins is providing new and sometimes unanticipated insights into molecular details of the regulation of cell signalling pathways and the behaviour of receptor ligands. Genome editing is certain to become a central component of therapeutic target validation, and will provide pharmacologists with new understanding of the complexities of action of novel and previously studied ligands, as well as of the transmission of signals from individual cell-surface receptors to intracellular signalling cascades.

Original languageEnglish
Pages (from-to)481-493
Number of pages13
JournalTrends in Pharmacological Sciences
Volume39
Issue number5
DOIs
Publication statusPublished - 2018 May

Keywords

  • CRISPR/Cas9
  • G protein
  • G protein-coupled receptor
  • arrestin
  • genome editing

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'Genome Editing Provides New Insights into Receptor-Controlled Signalling Pathways'. Together they form a unique fingerprint.

  • Cite this